QUIDELORTHO CORP Employee Benefits and Share-based Compensation
QUIDELORTHO CORP (QDEL) reported Employee Benefits and Share-based Compensation of $4.50 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-08-07
- QUIDELORTHO CORP employee benefits and share-based compensation for the quarter ending 2026-06-28 was $4.50M.
- QUIDELORTHO CORP employee benefits and share-based compensation for the quarter ending 2026-03-29 was $5.50M.
- QUIDELORTHO CORP employee benefits and share-based compensation for the quarter ending 2024-12-29 was $0.00.
- QUIDELORTHO CORP employee benefits and share-based compensation for the quarter ending 2024-09-29 was $0.00.
- QUIDELORTHO CORP employee benefits and share-based compensation for fiscal 2024 was $5.60M.
- QUIDELORTHO CORP employee benefits and share-based compensation for fiscal 2023 was $3.20M.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|
| 2026-06-28 | $4.50M 10-Q · filed 2026-08-07 | $10.00M 10-Q · filed 2026-08-07 | ||
| 2026-03-29 | $5.50M 10-Q · filed 2026-05-06 | |||
| 2024-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $5.60M 10-K · filed 2026-02-19 |
| 2024-09-29 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $5.60M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 | $5.60M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $5.60M 10-Q · filed 2025-05-08 | |||
| 2023-10-01 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | $1.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | $0.00 10-Q · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | $1.70M derived: sum of 3 quarters · filed 2025-02-27 | $2.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $0.00 10-Q · filed 2024-05-09 | $1.70M derived: sum of 2 quarters · filed 2025-02-27 | $2.70M derived: sum of 3 quarters · filed 2025-02-27 | |
| 2023-01-01 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.70M derived: sum of 2 quarters · filed 2025-02-27 | $3.20M 10-K · filed 2025-02-27 | |
| 2022-10-02 | $1.00M 10-Q · filed 2023-11-02 | $1.50M 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |